Skip to content

Three dimensional approach for management of weight and eating habits in Polycystic Ovarian Syndrome

Three dimensional healthcare approach for â??healthy weightâ?? and â??healthy eatingâ?? in Polycystic Ovarian Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038113
Enrollment
142
Registered
2021-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Exercise, diet counselling, Raj yoga meditation: Participants will visit Obstetrics and Gynecology OPD in Fortis Memorial Research Institute 3 days a week (for 12 weeks) for supervised

Sponsors

Renuka Jakhar
Lead Sponsor
Dr Preeti Rastogi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) PCOS diagnosed on basis of Rotterdam criteria(2) BMI more than 18.5 and less than 25(3) Females not following lifestyle modifications/ not taking medications for PCOS for past 6 months(4) Willing to participate in study(5) Ready to avoid shaving or depilatory methods(6) Females not pregnant.

Exclusion criteria

Exclusion criteria: Not meeting the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
â?¢BMI â?¢Waist-Hip Ratio â?¢Serum Testosterone â?? Free and Total â?¢Fasting and Post Prandial Insulin â?¢Fasting and Post Prandial Blood Sugar â?¢Pelvic/abdominal Ultrasound â?¢Polycystic Ovary Syndrome Questionnaire (PCOSQ) score â?¢SF-36 score â?¢EAT 26 score â?¢EDDS score â?¢Hospital Anxiety and Depression Scale (HADS) score â?¢Perceived stress scale score â?¢BITE scoreTimepoint: 12 weeks

Secondary

MeasureTime frame
17alpha OH Progesterone Timepoint: 12 weeks;DHEA Timepoint: 12 weeks;Estradiol Timepoint: 12 weeks;Follicle Stimulating Hormone Timepoint: 12 weeks;Leutinizing Hormone Timepoint: 12 weeks;Prolactin Timepoint: 12 weeks;Serum Cortisol Timepoint: 12 weeks;Thyroid Stimulating HormoneTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Elina Dewanji Sen

G. D. Goenka University

elina.dewanji@gdgu.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026